Imara
clinical development strategy i | Imara
Company
Deck Type
Deck date
October 2022
Slide
30 of 45
Related slides by other companies
Valneva
IPO
April 2021
in subjects clinical data in phase clinical trial published in lancet | Valneva
Valneva
IPO
April 2021
development outlook pivotal phase trial topline read out expected mid | Valneva
Compass Therapeutics
Investor Presentation
May 2023
clinical development plans | Compass Therapeutics
MaxCyte
Investor Presentation
August 2023
enabled active clinical trials | MaxCyte
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights